Cite

HARVARD Citation

    Scherl, E. et al. (n.d.). DOP86 Corticosteroid-sparing effects of ustekinumab therapy for Ulcerative Colitis through 3 years: UNIFI long-term extension. Journal of Crohn's and colitis. pp. S117-S118. [Online]. 
  
Back to record